Robeco Institutional Asset Management B.V. Purchases New Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Robeco Institutional Asset Management B.V. bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 11,033 shares of the company’s stock, valued at approximately $763,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HSIC. FMR LLC boosted its position in shares of Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after buying an additional 237,888 shares during the period. Southpoint Capital Advisors LP raised its position in shares of Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after purchasing an additional 600,000 shares during the period. Nuance Investments LLC lifted its holdings in Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares during the last quarter. Clarkston Capital Partners LLC boosted its holdings in Henry Schein by 5.4% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after purchasing an additional 71,560 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Henry Schein by 0.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock worth $85,662,000 after purchasing an additional 6,184 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

HSIC has been the subject of several recent analyst reports. Evercore ISI upped their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho assumed coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Seven analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $80.10.

Insider Buying and Selling at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Trading Up 1.3 %

NASDAQ HSIC opened at $80.58 on Wednesday. The company has a market capitalization of $10.05 billion, a price-to-earnings ratio of 33.16, a PEG ratio of 2.21 and a beta of 0.91. The stock’s 50-day simple moving average is $73.53 and its two-hundred day simple moving average is $71.60. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.32 earnings per share. Research analysts forecast that Henry Schein, Inc. will post 4.76 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.